10/06/2007 Immune System Cancer
An new study presented at the Congress of the European Hematology Association in Vienna (A) showed that survival rates are improved using intensive rather than conventional therapies. The results were so clearly in favor of intensive therapy that conclusions could be reached before the study was completed, Italian scientists reported in Vienna.
10/06/2007 The Bloodgen Project: Improving the Blood Supply
The era in which standard serology tests divided populations into two basic blood groups, ABO and Rh, may soon be a thing of the past. Nearly a century after blood group analysis began, new technologies for genotyping of blood offer a far more accurate picture of blood groups, experts reported at the 12th Congress of the European Hematology Association.
10/06/2007 Mechanisms of Leukemia
There are still many unsolved mysteries surrounding cancer, especially leukemia. Why does what seems to be the same type of cancer respond to the same therapy in one case but not in another? The latest in modern genetic analyses reveal what incredibly diverse modes of action are involved and point the way to new therapies.
09/06/2007 Increased Susceptibility to Thrombosis
Thromboses can be fatal. In fact, in our part of the world their consequences are the third most common cause of death. That makes it all the more important to recognize risk factors and to derive from them new methods of prevention and therapy. Revolutionary discoveries on this subject have been made by the Dutch coagulation researcher Professor Rogier Bertina. In recognition of this fine work, he was singled out to receive the José Carreras EHA Award at the Congress of European Hematologists in Vienna. New treatment options could protect many at-risk patients.
09/06/2007 Donating Stem Cells
Donating stem cells is almost free of risk for donors and is often the only chance of survival for many patients with certain severe blood or bone marrow diseases. This was the conclusion arrived at in an observation study conducted by the Medical University of Hanover and just presented at the Congress of the European Hematology Association in Vienna.
09/06/2007 Transplantation in Osteopetrosis
Experts present an analysis of long term data on the success of stem cell transplantation for osteopetrosis patients which suggests second transplants should be considered a key option.
09/06/2007 Decreasing Drug Toxicity
Pharmacogenomics offers the promise of individualized drug therapies based on a patient's genetic make-up and that of the tumor cells. Such tailor-made drug regimes hold the promise to further increase survival rates for cancer. They could also decrease the sometimes lethal side effects of the powerful drugs used in cancer therapy, experts reported at the 12th Congress of the European Hematology Association in Vienna.
09/06/2007 Dangerous Form of Anemia
Until now a person suffering from paroxysmal nocturnal hemoglobinuria, a degenerative disease of the red blood cells, had a 50:50 chance of dying prematurely from a thromboembolism. A new drug reduces this risk by 85%.
08/06/2007 Care in Blood Diseases
Hematological diseases are more widespread than is commonly assumed. More than 175.000 people in the countries of the European Union and more than 267.000 people in the larger Europe are newly diagnosed of malignant blood disorders such as leukemia and lymphoma every year, and several millions are afflicted by non-malignant illnesses such as anemia and thrombosis. The European Hematology Association (EHA), at its 12th Congress in Vienna, Austria, presents activities that aim at ensuring medical improvements reach as wide a patient base in Europe as possible.
08/06/2007 Private Blood Banking
Blood from the umbilical cord is considered to be a valuable “biological raw material” today that can help to cure illness. An increasing number of parents have private blood banks freeze the stem cells from the blood in their child’s umbilical cord and spare no expense to do so. But experts at the Congress of the European Hematology Association in Vienna say that the benefits of this supposedly preventive measure is controversial. Putting cord blood in public banks, on the other hand, is an act of solidarity that could provide stem cells to affected patients who need them. Possible future options may be hybrid public-private blood banks.
08/06/2007 Economy Class Syndrome
Air travel is associated with a two- to threefold increased risk of developing thrombosis, experts said at the 12th Congress of the European Hematology Association (EHA) in Vienna (Austria). Doctors urge the EU and national governments to help make air travel safer by supporting research into preventing travelers’ thrombosis.
08/06/2007 Multiple Myeloma
Multiple myeloma, an insidious form of bone marrow cancer, has lost an important battle. New drugs are now showing an effect where no help was available just a short time ago and up to90% of myeloma patients stand to benefit.
08/06/2007 Haemophilia Therapies
Haemophilia is a genetic disease perhaps best known for the tragic effects it had on Russia’s former imperial family. The curtailment to a sufferer’s freedom is immense, when in severe cases any injury causing bleeding can be life-threatening. New developments in gene therapy and in classical medical treatments for haemophilia outlined at the European Hematology Association Congress in Vienna suggest significant improvements in quality of life for those afflicted may be within reach.
06/06/2007 Blood Disorders
3rd Notice of and Invitation to 12th Congress of the EHA - European Hematology Association.
More than 6.500 participants from around 100 European and non-European countries will gather at the upcoming 12th Congress of the EHA in Vienna (Neue Messe Vienna) from June 7-10, 2007. The EHA Congress is organized by the European Hematology Association. (President: Prof. Eva Hellström-Lindberg, Stockholm) with local congress president (Prof. Dr. Heinz Ludwig, Vienna) and an international Scientific Program Committee (Chair: Prof. Dr. Irene Roberts, London).
Please find below the latest information for media representatives interested in this major scientific event.
18/05/2007 Hematologists Gather in Vienna
2nd Notice of and Invitation to 12th Congress of the EHA - European Hematology Association.
More than 6.500 participants from around 100 European and non-European countries will gather at the upcoming 12th Congress of the EHA in Vienna (Neue Messe Vienna) from June 7-10, 2007. The EHA Congress is organized by the European Hematology Association. (President: Prof. Eva Hellström-Lindberg, Stockholm) with local congress president (Prof. Dr. Heinz Ludwig, Vienna) and an international Scientific Program Committee (Chair: Prof. Dr. Irene Roberts, London).